CMS home care demo sees reduced savings in second year

A CMS analysis said its Independence at Home Demonstration program saved over $10 million in its second performance year, a decline from the $25 million in savings from its first year.

The reduction in savings came despite the program serving more beneficiaries in its second year, with more than 10,000 among 15 participating practices compared to more 8,400 in 17 practices in the first year. The agency focused on the positive results in its press release, saying the program continued to improve care and lower costs for chronically ill beneficiaries being treated at home.

“The Independence at Home Demonstration is a patient-centered model that supports providers in caring for chronically ill patients in their own homes,” said Patrick Conway, MD, CMS acting deputy administrator and chief medical officer. “These results continue to support what most patients already want – the ability to have high quality care in the home setting”.

The performance of practices appeared to have declined slightly based on the following quality measures:

  • Follow up contact within 48 hours of a hospital admissions, hospital discharge, and emergency department visit.
  • Medication reconciliation in the home within 48 hours of a hospital discharge and emergency department visit.
  • Annual documentation of patient preferences.
  • All-cause hospital readmissions within 30 days.
  • Hospital admissions for Ambulatory Care Sensitive Conditions.
  • Emergency department visits for Ambulatory Care Sensitive Conditions.

In the first year, all 17 participants improved quality in at least three of the six categories. For year two, the 15 participants improved in just two of the six. In both years, four practices met performance standards in all six categories.

The decline in performance may have led to CMS awarding less in incentive payments to practices that “succeeded in reducing spending while improving quality.” Seven practices received a total for $5.7 million in incentives in the second year, down from $11.7 million for nine practices in the first year.

The savings the model has achieved haven’t gone unnoticed by policymakers. In July, U.S. Sen. Edward Markey, D-Massachusetts, introduced the Independence at Home Act, which would convert the demonstration into a nationwide program.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.